The hepatic iron concentration (HIC) is widely used in clinical practice and in research; however, data on the variability of HIC among biopsy sites are limited. One aim of the present study was to determine the variability of HIC within both healthy and cirrhotic livers. Methods: Using colorimetric methods, we determined HIC in multiple large (microtome) and small (biopsysized) paraffin-embedded samples in 11 resected livers with end-stage cirrhosis. HIC was also measured in multiple fresh samples taken within 5 mm of each other ("local" samples) and taken at sites 3-5 cm apart ("remote" samples) from six livers with end-stage cirrhosis and two healthy autopsy livers. Results: The within-organ SD of HIC was 13-1553 g/g (CV, 3.6 -55%) for microtome samples and 60 -2851 g/g (CV, 15-73%) for biopsy-sized samples. High variability of HIC was associated with mild to moderate iron overload, because the HIC SD increased with increasing mean HIC ( P <0.002). Livers with mean HIC >1000 g/g exhibited significant biological variability in HIC between sites separated by 3-5 cm (remote sites; P <0.05). The SD was larger for biopsy-sized samples than for microtome samples (P ‫؍‬ 0.02). Conclusion: Ideally, multiple hepatic sites would be sampled to obtain a representative mean HIC.
alcoholic liver disease, viral hepatitis, or end-stage liver disease from various causes may have mild to moderate iron overload (3) (4) (5) (6) (7) (8) . Associations between HIC and disease must be interpreted in the context of variability in HIC measurements. Generally, only small amounts of tissue obtained from a single site via percutaneous needle biopsies are available for measurement of HIC. Poor precision for such measurements could potentially influence the diagnostic conclusions. Because of the wide use of HIC in the diagnosis of HHC and the assessment of iron overload, it is important to examine the degree of biological and analytical variability in HIC measurements. A random measurement of HIC from a small amount of tissue at a single site may be insensitive and nonspecific.
In this study, we provide quantitative estimates of the variability in HIC measurements, especially among patients with ESLD. The specific goals of our study were: (a) to quantify interorgan variability in HIC; (b) to quantify total intraorgan variability in HIC; (c) to estimate the components of total intraorgan variability attributable to local variability (measurements within 5 mm of each other) and to remote variability (measurements 3-5 cm apart); (d) to determine whether remote variability is statistically significant; and (e) to quantify the influence of sampling method (biopsy-sized versus microtome sections) on HIC variability.
Materials and Methods subjects and sampling
Subjects included were grouped into two series, A (n ϭ 11) and B (n ϭ 8). The primary purpose of the series A experiment was to determine the effect of sampling method on variability of HIC measurements, comparing two frequently used methods: needle biopsy and microtome sampling. Multiple biopsy-sized and microtome
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samples were taken at random sites from the livers of 11 consecutive patients undergoing orthotopic liver transplantation. Tissue samples were fixed in 100 mL/L neutral buffered formalin solution followed by routine paraffin embedding. Every paraffin block of hepatic tissue available from routine pathologic evaluation of the resected livers was assayed. Three to five blocks were available for each patient. Each block contained one to three separate tissue fragments taken from random locations over the liver. These tissue fragments were ϳ150 mm 3 in size and oblong in shape. From the end of each tissue fragment, one discrete needle-biopsy-sized sample was cut (mean, 2.5 mg; range, 0.5-7.7 mg dry weight). For each block, a 50-m thick cross-section (Ϸ75 mm 2 surface) was sampled by microtome (mean, 3.8 mg; range, 0.7-9.0 mg dry weight).
The hepatic disease etiologies in series A were as follows: hepatitis C virus (HCV) in three patients; alcoholic liver disease in one patient; HCV plus alcoholic liver disease in two patients; HCV plus ␣ 1 -antitrypsin deficiency in one patient; HCV plus heterozygosity for HHC in one patient (C282Y heterozygous, H63D wild-type); nonalcoholic steatohepatitis in one patient; and unknown in two patients. HFE genotyping for C282Y and H63D mutations was done in patients with HII Ն1.9 (9 ) .
The primary purpose of the series B experiment was to estimate the local and remote components of total intraorgan variability in HIC. Local variability was defined as variability among measurements within 5 mm of each other. Remote variability was defined as any excess over local variability that derives from measuring HIC at sites 3-5 cm apart. [This is a variance components model: total variance ϭ local variance ϩ remote variance (10 ) .] Remote variability may be attributed solely to biological variability, whereas local variability may be attributed to both analytic and biological variability. To allow estimation of these two components of variability, HIC measurements were made in fresh tissue from multiple adjacent biopsy-sized samples at three different remote sites within the right lobe of eight livers. Specifically, one fresh Ϸ 50-g (wet weight) specimen was taken from the right lobe of each liver. Three sites were chosen randomly from the perimeter of the 50-g specimen, and five discrete biopsy-sized samples were sampled sequentially from each site (mean, 3.4 mg; range, 0.9 -11.9 mg dry weight). These fresh samples were obtained from cirrhotic livers from six consecutive orthotopic liver transplantation patients and from two nonexplant livers removed at autopsy. In addition, microtome samples from the six cirrhotic livers in series B were taken in the same manner as in series A, with two to five paraffin blocks available from each liver (mean, 6.4 mg; range, 1.5-11.9 mg dry weight). This provided additional data to series A for the study of sample type.
Hepatic disease etiologies in series B were as follows: HCV in one patients; HCV plus ␣ 1 -antitrypsin deficiency in one patient; HCV plus alcoholic liver disease in one patient; alcoholic liver disease plus heterozygosity for the H63D mutation associated with HHC in one patient; and primary sclerosing cholangitis in two patients. The autopsy patients were without clinical, gross, or histologic liver disease.
iron assays
A colorimetric method was used to measure HIC in this study. Although many investigators use atomic absorption spectrometry for the determination of iron in tissue, colorimetry has been used in a number of important studies (8, (11) (12) (13) (14) (15) , and its comparability with atomic absorption for measurement of HIC has been established (16 ) . The colorimetric method is sufficiently sensitive for assay of the specimen sizes in this study (16 ) , is less costly, and is more commonly available than atomic absorption in clinical laboratories.
Tissue from paraffin blocks was washed twice in warmed xylene to remove paraffin. Both fresh and block samples were dried to constant weights in a Savant Speed Vac drying apparatus, weighed, and then digested at 65-75°C for 10 -15 min with 0.4 mL of concentrated nitric acid. After the pH was adjusted to 4.5 with sodium hydroxide and ammonium acetate buffer, the iron concentration was determined by a bichromatic endpoint method on the Dupont Dimension automated analyzer using disodium 3-(2-pyridyl)-5,6-bis-2(5-furyl sulfonic aid)-1,2,4-triazine (Ferene ® ) to form the chromogen (17 ) . The concentration of iron in the digests and the dry weight of the tissue was used to calculate g of iron per g of dry tissue (HIC). HII was calculated as HIC in mol/g dry weight divided by patients age in years (1 ).
quality control
The method was monitored for analytical variation by creation of control charts from HIC measurements on aliquots of a healthy liver homogenate. The intraassay CV for this control specimen was 2.7% (n ϭ 10; SD ϭ 54 g/g), and the interassay CV was 7.3% (n ϭ 91; SD ϭ 125 g/g).
statistical analyses
Paired t-tests, two-sample t-tests, Wilcoxon signed-rank tests, and Wilcoxon rank-sum tests were used for comparisons of HIC between groups as appropriate. Linear regression models were fitted by the method of least squares, and t-tests were used to determine the significance of regression coefficients. Distributional normality was assessed by the Kolmogorov-Smirnov test. In series B, the ANOVA method was used to estimate the local and remote components of variability for the biopsy-sized measurements from each liver individually. Standard F-tests were used to determine whether the remote variability component was significantly greater than zero (10 ) .
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Results

series a
For each liver in series A, means and SDs of HIC measurements were calculated for biopsy-sized and microtome samples (Table 1 ). There was large interorgan variability in HIC, demonstrated by the large range in mean HIC (307-5165 g/g for microtome samples, 260 -5290 g/g for biopsy samples). Mean HIC measurements obtained by the two sampling techniques were not significantly different (P ϭ 0.62, paired t-test). The distribution of HIC measurements within each liver did not differ from a gaussian distribution, with the exception of one case (P Ͼ0.05 for 10 livers; P ϭ 0.001 for case 8 by the Kolmogorov-Smirnov test.)
Intraorgan variability was high for some, but not all, livers. Intraorgan variability of HIC measurements, quantified by SDs of the measurements, varied widely across livers, ranging from 28 to 1553 g/g (mean, 477 g/g) for microtome samples and from 86 to 2851 g/g (mean, 717 g/g) for biopsy-sized samples (Table 1 and Fig. 1 ). SDs were significantly higher for biopsy-sized samples than for microtome samples (P ϭ 0.05, Wilcoxon signed-rank test). For both sampling methods, there were large and statistically significant increases in HIC SD as mean HIC increased (P Ͻ0.002 for both sample types; Fig. 1C ). The SD increased with the mean in such a manner that the CV did not change significantly as a function of mean HIC for either sampling method (P Ͼ0.05; Table 1 ).
Variability in HII reflected variability in HIC. HII means and ranges for series A livers are shown in Table 1 . Three of 11 livers had at least one HII value Ն1.9, a value often used as a criterion for HHC (1 ) . The liver from a patient with HCV and HHC heterozygosity had a mean HII of 2.4 (case 10). The HII range (0.1, 2.8) for biopsysized samples from case 11 (diagnosis of alcoholic liver disease) was illustrative of the high variability in these measurements from patients with high mean HIC.
series b
As with series A, there was large interorgan variability in HIC for series B livers (Table 2) . Among the cirrhotic livers, mean HIC ranged from 352 to 8010 g/g for the microtome samples and from 254 to 3946 g/g for the biopsy-sized samples. HIC means from the biopsy-sized samples for the two healthy livers were 443 and 1741 g/g. There was no significant difference between HIC means determined by the microtome and biopsy sampling methods (P ϭ 0.6, Wilcoxon signed-rank test). Again, intraorgan variability was very high for many of the livers (Fig. 2) . SDs ranged from 13 to 532 g/g for the microtome samples and from 60 to 1813 g/g for the biopsy-sized samples (Table 2 ). On average, SDs from the biopsy-sized samples were 290 g/g higher than those from the microtome samples, but this difference did not reach statistical significance for series B livers along (P ϭ 0.2, Wilcoxon signed-rank test). SDs for measurements from the biopsy-sized samples were significantly higher than SDs from microtome samples in the two series combined (mean difference, 261 g/g; P ϭ 0.02, Wilcoxon signed-rank test). Total SDs of fresh biopsy-sized samples varied significantly with mean HIC (P ϭ 0.0003) according to the regression equation: SD ϭ Ϫ157 ϩ 0.47 ϫ mean HIC. A significant linear relationship between total SD and mean HIC also was found for the microtome samples in Series B (P ϭ 0.01).
For four of the eight livers in series B, the remote variability component (additional variability between sites separated by 3-5 cm) was significantly greater than zero ( Table 3 ). The remote SD (square root of the remote variance component) increased significantly with increasing mean HIC (P ϭ 0.0004), and the livers with significant remote variability all had mean HICs Ն982 g/g. Local SDs also increased with mean HIC but to a lesser extent than did remote SDs (Fig. 2B) . The CVs for local samples were significantly lower than CVs based on total variability (P ϭ 0.008 by the Wilcoxon signed-rank test; Table 3 ).
As noted above, variability was significantly lower for microtome samples. This difference may be attributed to differences in sample weight. Dry weights of the microtome cross-sections were significantly higher than dry weights of the biopsy-sized samples in both series. (series A: mean dry weight, 3.8 and 2.5 mg, respectively; P ϭ 0.0001; series B: 6.4 and 3.4 mg, respectively; P Ͻ0.0001). A regression of SD on mean sample weight showed that the SD decreased by 120 g/g for every 1-mg increase in Clinical Chemistry 45, No. 3, 1999 sample dry weight for dry weights between 1.4 and 7.3 mg (P ϭ 0.008 after controlling for mean HIC).
To examine the possibility that formalin fixation and paraffin preservation has an effect on variability, SDs from the biopsy-sized samples in series A (paraffinpreserved) and series B (fresh) were compared using a regression model to control for mean HIC. Mean dry weights of the biopsy-sized samples were not significantly different in the two series, and there was no significant difference in SDs for the two kinds of sample preparations.
Means and ranges for series B HIIs are given in Table  2 . One of the six patients had at least one HII value Ն1.9 (case 6, diagnosis of alcoholic liver disease plus heterozygosity for the H63D mutation associated with HHC).
An analysis of mean HIC or variability in HIC by diagnosis is difficult because of the diversity of diagnoses. When series A and B were combined to obtain a larger sample size, none of the diagnoses was found to be associated with higher variability in HIC measurements. One autopsy liver from a patient without hepatic disease had high HIC (1741 g/g; Table 2 , case 7), and the SD of HIC measurements from this liver were accordingly high, as predicted by the linear regression results.
Discussion
Precise and accurate measurements of HIC are necessary for accurate diagnoses and research on the association between HIC and disease state or response to therapy. In this study, we have shown that single HIC measurements can be very imprecise in livers with moderately high mean HIC and that precision decreases as the overall iron load of the liver increases. These results can be used to gauge the precision of an individual HIC measurement. For example, an HIC measurement of 1000 g/g from a fresh biopsy-sized samples has an estimated SD of 310 g/g (from the regression equation). This yields a 95% confidence interval of 392-1608 g/g for the mean HIC for that liver (18 ), a range which covers both normal and increased values. If a confidence interval of width no greater than ϮK g/g is desired, in this case n measurements from remote sites in the liver are needed, where n ϭ (1.96 ϫ 310/K) 2 . These results extend the results of other reports indicating that there often exists high intraorgan variability in hepatic iron distribution and HIC measurements. Both Ludwig et al. (7 ) and Deugnier et al. (8 ) noted considerable intraorgan variability in iron staining and found wide intraorgan ranges in HII for a large proportion of cirrhotic livers studied. Results similar to ours relating HIC means and SDs can be reproduced from Table 2 In an earlier study performed to compare atomic absorption and colorimetric measurements of HIC (16 ) , it was noted incidentally that "sampling variation exceeds by far the analytic variation". Intraorgan CVs ranged from 16% to 22% for healthy liver and from 50% to 80% for cirrhotic liver measurements [estimated from Table III of Ref. (16 )]. In another early study done to establish reference intervals for HIC (13 ) , it was concluded by subjective inspection of measurements from three locations in nine healthy livers that there was "negligible" intraorgan variability in HIC. However, calculations from Table II of this last report show intraorgan SDs as high as 485 g/g, even in healthy livers (13 ) .
It is important to try to understand the relationship between the results above showing high HIC variability and those of Overmoyer et al. (14 ) , who concluded that one sample of liver tissue was representative of the whole organ. Careful evaluation of the latter report shows that there is not necessarily a conflict in the results, although the conclusions drawn differ. Overmoyer et al. point out that their series included no patients with disorders that might lead to a nonuniform distribution of iron, and all had health-related concentrations of (non-heme) liver iron. An important point of the present study is that high variability is most likely to occur when liver iron is increased. Furthermore, Overmoyer et al. (14 ) based their conclusion that iron is uniform within livers on the finding that there was no statistically significant intraliver variation in (non-heme) iron (page 553, column 2). The absence of statistical significance does not rule out large and clinically relevant variability because confidence intervals for the variability can contain very large values if the design and analysis had low statistical power (18 ) . Because the actual estimates of variability with confidence intervals were not reported, it is difficult to judge whether this might have been the case. Finally, Overmoyer et al. (14 ) found that none of the six hepatic sites at which they measured iron tends to collect more iron than in the others on average in their study population. They conclude from this that "iron is uniformly distributed within the liver". However, the lack of an average effect does not preclude random fluctuations within individual livers. Given these considerations, it appears inappropriate to make sweeping application of the conclusion by Overmoyer et al. (14 ) that one HIC measurement from a biopsy-sized sample is adequately representative. Although the discussion above deals with total variability in HIC measurements, our study design in series B allowed us to separate total variability into remote and local components. Remote variability is of special interest because it can be attributed solely to biological variability, i.e., "true" heterogeneity, in iron distribution as opposed to analytic variability (10 ) . We found that livers with HICs above ϳ1000 g/g had remote variability in HIC that was both clinically and statistically significant. The sites measured here were typically 3-5 cm apart, indicating macroscopic variability within the liver. The finding of significant biological variability in HIC when mean HIC is high is consistent with the observation that abnormal iron deposition can be uneven or granular (7, 20 ) . The increase in SD with increasing mean HIC also points to uneven iron deposition as the source of this effect. For repeated measurements where analytic variation is the main source of variation, SDs would be expected to increase little or not at all with increasing HIC (and CVs would decrease). This was not the case here.
The local variability component in this study contains analytic variability and may contain biological variability as well. The intraassay SD of 54 g/g for the qualitycontrol specimen can be taken as an estimate of the analytic variability here. Comparison of this figure with the local SDs in Table 3 suggests considerable local biological variability in some cases.
One consequence of these findings is that a single high HIC measurement is especially unreliable, and the variability in the HIC measurements on any given liver cannot be predicted before some HIC measurements have been made. This latter problem might be ameliorated to some degree if a good correlate of mean HIC was known in advance of the HIC measurement. This would allow a rough estimate of mean HIC, which would allow a prediction of variability through the mean/SD relationship. Serum ferritin and serum transferrin saturation have been found to correlate poorly with HIC (21 ) . However, biological correlation may actually be high, whereas the observed correlation is low because of unreliability of the HIC measurements (22 ) . In this case, these serum measures may prove useful in predicting HIC variability. Further research is needed to address this question.
Variability is quantified in this study mainly in terms of the SD rather than the CV because the 95% confidence interval for the true mean HIC depends directly on the SD and the number of repeated measurements (18 ) . Clinical interest in HIC usually centers on determining the mean for a given liver and whether it exceeds a particular threshold. The SD quantifies the variability in the measured mean and can be used directly to determine the likelihood that the true mean HIC exceeds any threshold of interest, whereas the CV cannot. In addition, comparison of CVs across laboratories is inappropriate if mean values are subject to shifts across laboratories (23 ) , which may be the case for HIC (24 ) . Additionally, because they are ratios of other estimated quantities, computed CVs can be very unstable estimates of the true CV, leading to low power to detect differences in CVs even when comparison is appropriate.
Microtome sampling gave more precise measurements than biopsy-sized sampling in this study, probably because of the larger size of the microtome samples. However, other differences between the microtome and biopsy-sized sampling methods could theoretically account for some of the difference found here. For example, the greater cross-sectional area sampled with the microtome might contribute. In a previous study, variability was found to be significantly lower in biopsy samples with dry weights Ͼ4 mg compared with the variability in biopsy samples with dry weights Ͻ4 mg (19 ) . Assuming that larger weight accounts for lower variability of microtome samples, our results show that the decrease in variability has practical significance as well as statistical significance because SDs were reduced by 120 g/g for every 1-mg increase in sample weight.
Some studies have found that formalin fixation lowers HIC (19, 13, 25 ) , whereas others, including ours, have not (12, 15 ) . However, our study was not designed to address this specific question. The 95% confidence interval for the percentage of difference between mean HIC from fresh and fixed samples in this study does not rule out a difference as large as 60% in either direction, indicating low statistical power to detect a difference. The high variability in HIC that we have demonstrated here can lead to very low power to detect differences in mean HIC. Use of large sample sizes and (when applicable) pairing observations from the same biopsy as in Villeneuve et al. (19 ) are techniques that can increase the reliability of studies comparing HIC between groups.
HIC measurements have played a major role in the diagnosis of HHC. HII Ն1.9 is typically used as a diagnostic criterion for HHC (2 ) . Other researchers have cautioned recently that HII values can be high (e.g., Ն1.9) in cirrhotic livers in the absence of HHC (7, 8 ) . The results of this study corroborate these previous findings, with 4 of 17 patients having at least one HII measurement Ն1.9. We have shown that two factors contribute to this finding: overall (mean) HIC concentrations can be very high in cirrhotic livers, and high variability increases the likelihood of finding high values for single measurements. Recently, the putative gene associated with HHC has been Clinical Chemistry 45, No. 3, 1999 identified and named HFE (9 ) . Two mutations associated HHC have been identified in this gene, C282Y and H63D (9, 26 ) . The homozygous C282Y mutation appears to be present in 80 -90% of persons of northern European descent who have the phenotypic expression of HHC. The availability of this genetic test has had a major impact on the diagnosis of HHC. It should be especially useful in the setting of end-state cirrhosis, where single HIC measurements can be highly variable. However, it mut be remembered that the C282Y mutation may be absent in some patients with a phenotypic expression of HHC (9, 26 ) . For such patients, careful clinical assessment and family studies will remain essential to identify patients with HHCrelated hepatic iron overload.
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